Annual Drug Patent Expirations for BYFAVO
Byfavo is a drug marketed by Acacia and is included in one NDA. It is available from one supplier. There are eleven patents protecting this drug.
This drug has forty-four patent family members in twenty-four countries.
The generic ingredient in BYFAVO is remimazolam besylate. One supplier is listed for this compound. Additional details are available on the remimazolam besylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
